5/18
Perelman School of Medicine
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
Mapping pancreatic cancer to improve immunotherapy
Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer.
‘Dual target’ cell therapy appears to shrink brain tumors
Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors.
Building a more diverse health care workforce across the Delaware Valley
Iris Reyes, who founded the Alliance of Minority Physicians in 2012, is working to expand the program to underrepresented students and professionals across the region.
Helping Black families to grow and thrive
To reverse the nationwide trend of serious harm and death before, during, and after childbirth for Black and other parents from marginalized groups, Penn Medicine is taking bold action to improve maternal health and eliminate racial disparities.
Penn Vet launches mRNA Research Initiative
The University of Pennsylvania School of Veterinary Medicine today announced the mRNA Research Initiative to advance veterinary vaccine science.
What makes a breakthrough? ‘Eight steps back’ before making it to the finish line
Four of Penn’s Breakthrough Prize recipients, Carl June, Katalin Karikó, Virginia M-Y Lee, and Drew Weissman, were honored at a reception on Feb. 13.
Killings of unarmed Black people and racial disparities in sleep health
Penn Medicine research finds that Black adults across the U.S. suffer from sleep problems following exposure to news about unarmed Black individuals killed by police during police encounters.
Helping hospitalized patients address addiction with empathy
Certified recovery specialist Eric Ezzi brings compassionate care to for patients dealing with substance use, a role that is part Penn Medicine’s efforts to address the urgent drug addiction crisis.
Imaging just one week after starting treatment can predict melanoma response to immunotherapy
New Penn Medicine research shows that following a single dose of a particular immunotherapy drug, CT scans “lit up” with metabolic changes in tumors that correlated with longer survival.
In the News
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
It’s time to end the Medicare-Medicaid merry-go-round
In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.
FULL STORY →
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →
Broad Street runners from Penn are racing with gyroscopes to study the Achilles tendon
Casey Jo Humbyrd and Josh Baxter of the Perelman School of Medicine and colleagues will track data from running the Broad Street Run to understand how a healthy Achilles tendon functions.
FULL STORY →